Sanofi India Ltd - 500674 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sanofi India Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed. Sanofi India Ltd - 500674 - Results Of Postal Ballot
We would like to inform you that the Ordinary Resolution in the Postal Ballot Notice dated 14th February 2022 has been passed by the members of the Company with requisite majority. Please find enclosed: 1. Voting results pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Report of Scrutinizer dated 25th March 2022. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the newspaper publication related to notice of the Annual General Meeting which will be held through video conferencing facility on 26th April 2022, published today, in newspapers, Business Standard and Sakal.
Dividend stocks: These 2 companies to soon pay special dividends. Details here
Sanofi India has recommended a final dividend of 181 per equity share and a special dividend of 309 per equity share Sanofi India Ltd - 500674 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24(A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, Secretarial Compliance Report for the year ended 31st December 2021, issued by Ms. Kumudini Bhalerao, Practicing Company Secretary of M/s. Makarand M. Joshi & Co. Company Secretaries
Buy Sanofi India: target of Rs 9250: Sharekhan
Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9250 in its research report dated March 02, 2022. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice to shareholders of the Company published today, in newspapers, Business Standard and Sakal.
Earnings Call for Q4CY21 of Sanofi India Ltd.
Conference Call with Sanofi India Management and Analysts on Q4CY21 Performance and Outlook. Listen to the full transcript.
Buy Sanofi India; target of Rs 8965: ICICI Direct
ICICI Direct is bullish on Sanofi India recommended buy rating on the stock with a target price of Rs 8965 in its research report dated February 24, 2022.